Recent Comments

Comment RSS

What is Smallpox?

Smallpox is an infectious disease unique to humans, caused by either of two virus variants, ''Variola major'' and ''Variola minor''. The disease is also known by the Latin names ''Variola'' or ''Variola vera'', which is a derivative of the Latin ''varius'', meaning spotted, or ''varus'', meaning "pimple". The term "smallpox" was first used in Europe in the 15th century to distinguish variola from the "great pox" (syphilis).

Smallpox localizes in small blood vessels of the skin and in the mouth and throat. In the skin, this results in a characteristic maculopapular rash, and later, raised fluid-filled blisters. ''V. major'' produces a more serious disease and has an overall mortality rate of 30–35%. ''V. minor'' causes a milder form of disease (also known as alastrim, cottonpox, milkpox, whitepox, and Cuban itch) which kills about 1% of its victims. Blindness resulting from corneal ulceration and scarring, and limb deformities due to arthritis and osteomyelitis are less common complications, seen in about 2–5% of cases.

Smallpox is believed to have emerged in human populations about 10,000 BC.

During the 20th century, it is estimated that smallpox was responsible for 300–500 million deaths. In the early 1950s an estimated 50 million cases of smallpox occurred in the world each year. After successful vaccination campaigns throughout the 19th and 20th centuries, the WHO certified the eradication of smallpox in December 1979.

Further Reading


This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Smallpox" All material adapted used from Wikipedia is available under the terms of the GNU Free Documentation License. Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.

Recent Smallpox News

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxinsIn an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have syn...Bavarian Nordic completes last step to support use of IMVAMUNE, receives FDA notificationBavarian Nordic A/S announced today that it has received notification that the U.S. Food and Drug Administration (FDA) has accepted all the actions taken by the company to address the observations mad...Cangene receives European Commission approval to market ImmunoGamCangene Corporation today reports that it has received European Commission approval to market Cangene's ImmunoGam(TM) (Human Hepatitis B Immunoglobulin), indicated for immunoprophylaxis of hepatitis B...WHO welcomes Gates Foundation support in advancing global vaccine effortsWHO welcomes the Bill & Melinda Gates Foundation pledge of US$ 10 billion over the next ten years to accelerate global vaccine efforts.Response Biomedical's 2009 total revenues up 69%Response Biomedical Corporation reported that it recorded total revenues of $9,946,269, an increase of 69% compared to $5,876,337 in 2008. Clinical products revenue for the year ended December 31, 200...
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.